Oppenheimer updated its outlook on Tarsus Pharmaceuticals (NASDAQ:TARS), a $1.8 billion market cap biotechnology company, increasing the price target to $72.00 from the previous $65.00 while ...

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), a $1.78 billion market cap company specializing in biological products, announced changes to its Board of Directors and committee assignments, according to ...

IRVINE, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- . (NASDAQ: TARS), today announced that management will participate in ...

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) was up 9% during trading on Monday after Barclays raised their ...

Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) had its price objective lifted by equities researchers at Barclays ...

Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today provided an update on the Company’s key priorities for 2025, including plans to advance TP-04 for the ...

Dealing with red, itchy eyelids? The culprit could be a common mite. This article is sponsored by XDEMVY. Dr. Watson is a paid consultant for Tarsus Pharmaceuticals.

The president offered a proclamation Saturday to begin duties on Canada, Mexico, and China. Musk says Tesla's robotaxis will hit Austin this summer. But after years of unfulfilled promises, investors ...

Tarsus Pharmaceuticals, Inc. has announced plans to advance TP-04, an investigational ophthalmic gel formulation of lotilaner, for the treatment of Ocular Rosacea, a significant but currently ...

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03 ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $60.0, a high estimate of $72.00, and a low estimate of $41.00. Surpassing the previous average ...

Local technology distributor Tarsus Distribution has announced that it will be bring the Self-Learning AI technology from cybersecurity firm Darktrace to African enterprises.